Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | RGC | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Regencell Bioscience Holdings Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 246.14 | 25.56 | 31.06 | ||
| High | 250.27 | 26.76 | 31.90 | ||
| Low | 236.22 | 25.34 | 28.32 | ||
| Latest | 238.66 | 26.43 | 29.28 | ||
| Change | -7.48 | -0.63 | -2.19 | ||
| % Change | -3.04% | -2.33% | -6.96% | ||
| Volume | 674,200 | 5,919,500 | 96,000 | ||
| 20-Day Average Volume | 840,940 | 1,866,340 | 107,500 | ||
| Previous Close | 246.14 | 27.06 | 31.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.63 | 27.42 | 29.08 | ||
| 20-Day Raw Stochastic | 65.01% | 26.65% | 39.63% | ||
| 20-Day Relative Strength | 53.62 | 43.89 | 52.07 | ||
| Weighted Alpha | +51.30 | +20.50 | +26.98 | ||
| Today's Opinion | 96% Buy | 64% Sell | 88% Buy | ||
| Previous Opinion | 96% Buy | 64% Sell | 88% Buy | ||
| Last Month's Opinion | 80% Buy | 32% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.03% since 05/01/26 | -0.08% since 05/01/26 | +0.55% since 05/01/26 | ||
| Low | 221.00 on 05/04/26 | 25.34 on 05/08/26 | 26.95 on 05/05/26 | ||
| High | 250.27 on 05/08/26 | 28.28 on 05/07/26 | 32.00 on 05/07/26 | ||
| 1-Month | |||||
| %Chg | +2.34% since 04/08/26 | -6.94% since 04/08/26 | +1.39% since 04/08/26 | ||
| Low | 216.22 on 04/29/26 | 25.34 on 05/08/26 | 26.51 on 04/27/26 | ||
| High | 250.74 on 04/13/26 | 29.43 on 04/14/26 | 33.50 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | +7.43% since 02/06/26 | -14.47% since 02/06/26 | +7.53% since 02/06/26 | ||
| Low | 211.00 on 02/12/26 | 24.95 on 03/20/26 | 20.00 on 03/09/26 | ||
| High | 250.74 on 04/13/26 | 31.41 on 02/17/26 | 40.00 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +20.69% since 11/07/25 | -7.78% since 11/07/25 | +124.88% since 11/07/25 | ||
| Low | 188.07 on 11/13/25 | 24.95 on 03/20/26 | 10.33 on 11/25/25 | ||
| High | 250.74 on 04/13/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,886,892 | 16,479,291 | 14,478,639 | ||
| Shares Outstanding, K | 62,377 | 623,507 | 494,489 | ||
| Annual Sales | 814,760,000 | 3,720,000,000 | 0 | ||
| Annual Net Income | -258,000,000 | 963,000,000 | -3,580,000 | ||
| Last Quarter Sales | 279,270,000 | 1,058,000,000 | N/A | ||
| Last Quarter Net Income | -42,910,000 | 31,000,000 | N/A | ||
| 60-Month Beta | 0.41 | 0.86 | 1.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.64 on 02/11/26 | 0.05 on 02/17/26 | N/A | ||
| Earnings Date | 08/06/26 | 08/06/26 | 01/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 02/15/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.47 | 0.00 | ||